Researchers at MIT and Harvard have developed CAR-NK cells—a type of immune cell engineered to be 'invisible' to the body's natural defenses—that can effectively target and destroy cancer cells without provoking dangerous immune reactions, showing potential as a major breakthrough in cancer treatment.
LIfT BioSciences, a pioneering biotech startup, is advancing the field of cancer treatment by harnessing the body's oldest immune cells to tackle one of medicine's most formidable challenges. Although cancer remains one of the leading causes of mortality worldwide, innovations in immunotherapy and engineered cell therapies offer new hope.
Researchers from Europe have engineered a synthetic molecule inspired by a natural bacterial compound, showing promise in enhancing chemotherapy effectiveness against cancer.
A cutting-edge RNA tool developed by SMART promises to enhance the identification of disease markers and foster personalized treatments for cancer and infectious diseases, potentially revolutionizing current medical practices.
Stay informed with curated insights delivered weekly to your inbox.